The Role Of Interleukin-17 In The Development And Severity Of Psoriasis

IL-17 is a member of the innate immune system, it is preferentially expressed by Th2 cells, and is highly recognized in psoriasis skin lesions. The current study aims investigate the role of Interleukin-17 (IL-17) in development and severity of psoriasis (PsO). Eighty persons from both genders are included in the study, 40 of them were patients and the same number were as control. Blood samples were taken from both groups and ELISA ready kit was used to estimate the sera levels of IL-17. The current findings pointed to a significant increase (p<0.05) in the of serum IL-17 in the patients’ group in comparison with the control group (20.97 ± 12.93 vs 20.97 ± 12.93 respectively). The results also showed that there is a highly significant increase in mean levels of IL-17 (20.3 pg/ml) in patients with moderate PsO and (20.8 pg/ml) for patients with severe PsO, compared to those with mild PSO. Conclusion: It was concluded that the high levels of IL-17 in psoriasis, and it seem that this interleukin may contribute to the severity of the disease. No gender differences were seen regarding the level of IL-17.